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Abstract
Objective-To document regional plasma concentrations of brain natriuretic factor (BNF) and their relations to concurrent concentrations of atrial natruretic factor, cyclic guanosine monophosphate, and haemodynamic state. Design-Regional blood sampling from a systemic artery and vein, renal vein, and coronary sinus together with concurrent haemodynamic indices in patients coming forward for left and right cardiac catheterisation. Setting-Tertiary referral centre. Patients-22 consecutive unselected patients coming forward for left and right cardiac catheterisation or electrophysiological studies in the course of standard diagnosis for a range of cardiac disorders. Main outcome measures-Significant arteriovenous gradients for plasma BNF concentration were found across the lower limb, the kidney, and the heart. These were less than concurrent arteriovenous gradients in plasma atrial natriuretic factor (ANF). Arterial concentrations of plasma BNF were positively related to concurrent concentrations of ANF (r = 0-72, p < 0.01) and cyclic guanosine monophosphate (r = 0*52, p < 0.05). Arterial plasma concentrations of BNF showed a significant positive correlation with right atrial pressure (n =22) (n =16) (n= 13) (n = 22) (n-16) (n = 13) catheters and transducers. Systemic arterial pressure and heart rate were also recorded. Blood samples were taken sequentially from the femoral artery, femoral vein, renal vein, coronary sinus, and finally a repeat sample was taken from the femoral artery. Right heart pressures and cardiac output were measured immediately after the sample from the coronary sinus. Right heart studies and blood samples were taken before introduction of any radiocontrast material into the circulation.
Blood was taken into chilled tubes that contained ethylene diamine tretraacetate and immediately centrifuged. Plasma was stored at -20°C before radioimmunoassay for BNF, ANF, and cGMP.10-12 We used a radioimmunoassay for human BNF previously developed10 to measure BNF in both normal subjects and in patients with heart failure. Briefly, BNF was extracted from human plasma with Vycor glass powder (mean extraction efficiency 79%). The assay used high performance liquid chromatography purified human 125I his, BNF32 and a specific BNF antiserum purchased from Peninsula Laboratories. The minimum detectable concentration was 0 45 fmol/tube and the IC50 9 fmol/tube. Within and between assay coefficients of variation for the assay were 7% and 10%. The normal range of plasma BNF was ascertained from samples from 48 normal volunteers (40 men) aged 18 to 70 years. Blood samples were taken after 30 minutes lying down. The normal range for BNF established from these data was 3-10 pmol/l. Mean (2SD) BNF plasma concentrations (6-3 (0-3 pmol/l) were significantly lower than mean concomitant ANF concentrations (0 6) pmol/l) in this group of normal subjects. 1) . The fall in BNF concentrations from femoral artery to vein (n = 22) was slight (a decrement of only 2 pmol/l(-6%)) but statistically significant (p < 0-01). In 13 patients in whom coronary sinus sampling was successful, cardiac secretion of BNF was indicated as coronary sinus concentrations of BN-F were on average more than double concurrent arterial values. A fall in BNF concentrations across the renal circulation (an average decrement of 7 pmolIl(-21%), p < 001) was found and this was consistently greater than concurrent falls between femoral artery and vein.
At all four sampling positions, mean plasma ANF concentrations were significantly greater than concurrent BNF concentrations, (fig 1, p<00l, p<0001 , p <0-05, p< 0-0001 for arterial, coronary sinus, renal venous, and femoral venous plasma). Absolute and proportional arteriovenous gradients for plasma ANF concentrations were significantly greater than those found in concurrent BNF concentrations. Plasma ANF fell by 35% between the femoral artery and vein (n = 22), increased by 528% between artery and coronary sinus (n = 13), and fell by 60% between artery and renal vein (n = 16). Cyclic GMP concentrations showed a small rise from femoral artery to vein (6-6 (07) to 7-5 (0'7 pmol/ml, p < 001) and no significant change from arterial to coronary sinus concentrations (5) (6) (7) (8) (0'9) to 6 1 (0 9-pmol/ml, NS). By contrast, there was a sharp decline in cGMP concentrations across the renal circulation (5 9 (0 7) to 3-1 (0 4) pmol/ml, p < 0 001).
Arterial concentrations of BNF (n = 22) were related to concomitant plasma ANF concentrations (r = 0 72, p < 0 001) and with cGMP (r = 0.52, p < 005). As expected ANF and cGMP were also positively related (r = 0-82, p < 0 0001). Figure 2 shows the significant inverse rela- tion of plasma BNF concentrations (arterial) to concurrent cardiac output and the positive relation with pulmonary artery wedge pressure. Plasma BNF was also significantly related to mean pulmonary artery pressure (r = 055, p < 0 05) and mean right atrial pressure (r = 0-51, p < 0 05) with these relations resembling that found between BNP and pulmonary artery wedge pressure. No relation with systemic arterial pressure was found. Similar relations occurred between plasma ANF concentrations and haemodynamic indices. Plasma ANF was inversely related to cardiac output (r= -045), p = 0.10, NS) and positively related to right atrial (r = 0.53, p < 0-05), pulmonary wedge (r = 0.53, p < 005), and mean pulmonary artery pressures (r = 0 55, p < 0 05). As in the case of plasma BNF, plasma ANF concentration showed no significant correlation with systemic arterial pressure.
Discussion
These data confirm that plasma BNF concentrations are raised in cardiac disease in proportion to the severity of haemodynamic dysfunction. BNF '8 In conclusion, in a group of patients with a range of cardiac disease, plasma BNF concentrations were raised above normal in proportion to the degree of haemodynamic impairment. Plasma BNF and plasma ANF concentrations were closely correlated and the two -peptides may complement each other in the overall neurohumoral response to cardiac dysfunction. BNF is clearly secreted from the heart and cleared across a similar array of organs as is ANF, but arteriovenous gradients are far less than those found in concurrent ANF concentrations suggesting a much slower clearance of BNF. Clearly, further observational and interventional studies are required to better define the roles, and the relative importance, of BNF and ANF in pressure and volume homeostasis in health and disease.
